LEPRE1 antibody
Principal name
LEPRE1 antibody
Alternative names for LEPRE1 antibody
LEPRE1, GROS1, P3H1, Prolyl 3-hydroxylase 1, EC=1.14.11.7, Leucine- and proline-enriched proteoglycan 1, Leprecan-1, Growth suppressor 1
Ncbi ID
9606, NP_071751, NP_001139761.1, NM_022356, NP_001035874.1, NM_019782, NM_019783, NM_053667, NM_001042411, NM_001146289
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Flow Cytometry (F), Luminex (LMNX)
Background of LEPRE1 antibody
- Kit Component:
- - KN309230G1, Lepre1 gRNA vector 1 in pCas-Guide vector
- KN309230G2, Lepre1 gRNA vector 2 in pCas-Guide vector
- KN309230D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunoperoxidase of monoclonal antibody to LEPRE1 on formalin-fixed paraffin-embedded human esophagus. [antibody concentration 6 ug/ml]
Immunofluorescence of monoclonal antibody to LEPRE1 on HeLa cell. [antibody concentration 10 ug/ml]
LEPRE1 monoclonal antibody (M01), clone 3C7 Western Blot analysis of LEPRE1 expression in HeLa ( Cat # L013V1 ).
Western Blot analysis of LEPRE1 expression in transfected 293T cell line by LEPRE1 monoclonal antibody (M01), clone 3C7.Lane 1: LEPRE1 transfected lysate(46 KDa).Lane 2: Non-transfected lysate.
Detection limit for recombinant GST tagged LEPRE1 is approximately 0.3ng/ml as a capture antibody.
LEPRE1 MaxPab polyclonal antibody. Western Blot analysis of LEPRE1 expression in human placenta.
Western Blot analysis of LEPRE1 expression in transfected 293T cell line (H00064175-T01) by LEPRE1 MaxPab polyclonal antibody.Lane 1: LEPRE1 transfected lysate(42.9 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of LEPRE1 expression in transfected 293T cell line (H00064175-T01) by LEPRE1 MaxPab polyclonal antibody.Lane 1: LEPRE1 transfected lysate(42.90 KDa).Lane 2: Non-transfected lysate.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505086), and then analyzed by flow cytometry.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505087), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Human liver tissue within the normal limits using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Human Ovary tissue within the normal limits using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505088)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505088), and then analyzed by flow cytometry.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505089), and then analyzed by flow cytometry.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505090), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-LEPRE1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505091)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505091), and then analyzed by flow cytometry.
Anti-LEPRE1 mouse monoclonal antibody (TA505105) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY LEPRE1(RC222535).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1 (RC222535, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LEPRE1.
HEK293T cells transfected with either RC222535 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LEPRE1 antibody(TA505105), and then analyzed by flow cytometry.
LEPRE1 ELISA with 1A1 Capture (TA600056) and 1B4 Detection (TA700057) Antibodies. Substrate used: Recombinant Human LEPRE1 (TP322535)
LEPRE1 Luminex with 1A1 Capture (TA600056) and 1B4 Detection (TA700057) Antibodies. Substrate used: Recombinant Human LEPRE1 (TP322535)
LEPRE1 ELISA with 1A1 Capture (TA600056) and 1B4 Detection (TA700057) Antibodies. Substrate used: Recombinant Human LEPRE1 (TP322535)
LEPRE1 Luminex with 1A1 Capture (TA600056) and 1B4 Detection (TA700057) Antibodies. Substrate used: Recombinant Human LEPRE1 (TP322535)
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA505088 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1H3 (formerly 1H3) | |||||||
 |
Mouse | IgG1 | OTI1H3 | Purified | Hu | F, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
 +10 additional images |
Highly validated antibody!
|
||||||
| TA505086 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1D2 (formerly 1D2) | |||||||
 |
Mouse | IgG1 | OTI1D2 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505087 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1F4 (formerly 1F4) | |||||||
 |
Mouse | IgG1 | OTI1F4 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505089 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1C4 (formerly 1C4) | |||||||
 |
Mouse | IgG1 | OTI1C4 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505090 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1A2 (formerly 1A2) | |||||||
 |
Mouse | IgG1 | OTI1A2 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505091 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1A1 (formerly 1A1) | |||||||
 |
Mouse | IgG1 | OTI1A1 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA505105 | LEPRE1 antibody |
||||||
| LEPRE1 mouse monoclonal antibody, clone OTI1B4 (formerly 1B4) | |||||||
 |
Mouse | IgG1 | OTI1B4 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA600056 | LEPRE1 antibody |
||||||
| ELISA and Luminex validated LEPRE1 mouse monoclonal antibody (clone 1A1, clone OTI1A1 (formerly 1A1) | |||||||
 |
Mouse | IgG1 | OTI1A1 | Purified | Hu | E, LMNX |
0.1 mg /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA700057 | LEPRE1 antibody |
||||||
| ELISA and Luminex validated biotinylated LEPRE1 mouse monoclonal antibody (clone 1B4), clone OTI1B4 (formerly 1B4) | |||||||
 |
Mouse | IgG1 | OTI1B4 | Purified | Hu | E, LMNX |
50 µg /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP322535 | LEPRE1 |
||||
| Recombinant protein of human leucine proline-enriched proteoglycan (leprecan) 1 (LEPRE1) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY411682 | P3H1 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR222340L2V | Lenti ORF particles, Lepre1 (GFP-tagged) - Mouse leprecan 1 (Lepre1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,540.00
|
|
| OriGene Technologies, Inc. | ||
| MR210385L2V | Lenti ORF particles, Lepre1 (GFP-tagged) - Mouse leprecan 1 (Lepre1), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,260.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR207814L2V | Lenti ORF particles, Lepre1 (GFP-tagged ORF) - Rat leucine proline-enriched proteoglycan (leprecan) 1 (Lepre1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,510.00
|
|
| OriGene Technologies, Inc. | ||
| RR207814L1V | Lenti ORF particles, Lepre1 (Myc-DDK-tagged ORF) - Rat leucine proline-enriched proteoglycan (leprecan) 1 (Lepre1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,350.00
|
|
| OriGene Technologies, Inc. | ||